(2S)-2-(2-oxopyrrolidin-1-yl)butanamide

Boehringer Ingelheim Roxane Inc

Revision date : 2008-12-05

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2008-12-05

Product name

(2S)-2-(2-oxopyrrolidin-1-yl)butanamide

Product Synonyms

None

Chemical name

(2S)-2-(2-oxopyrrolidin-1-yl)butanamide

CAS No.

102767-28-2

1.2.1 Relevant identified uses

Treatment of epilepsy

Manufacturer Name

Boehringer Ingelheim Roxane Inc

Icons in SDS

Company Information

company name

Boehringer Ingelheim Roxane Inc

GHS Information

Signal word

WARNING!

Section 2

SECTION 2: Hazards identification

Emergency Physical State: Liquid solution administered orally. Overview Clear, colorless, cherry-flavored solution with 100 mg of Levetiracetam per mL. Odor: No data available WARNING! May be harmful if swallowed. Accidental ingestion of large amounts may be harmful. Primary Route(s) of Entry Ingestion

Potential health effects

Inhalation: Not expected to be an inhalation hazard in final pharmaceutical form. Eye Contact: Not expected to be a hazard to the eye. Contact with eye may cause irritation, burning and redness. Skin Contact: Not expected to be a hazard to the skin. Can cause hypersensitive reactions resulting in rash, redness, itching and inflammation. Ingestion: May be harmful if ingested. Ingestion may cause central nervous system effects such as somnolence, fatigue, coordination difficulties and behavioral abnormalities. Toxicity Data: See Section 11 Effects of The potential for exposure is reduced in finished pharmaceutical form. Overexposure: Overexposure by ingestion may cause somnolence, agitation, aggression, depressed level of consciousness, respiratory depression and coma. Target Organs: Gastrointestinal tract

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.